Regidor PA, Colli E, Palacios S. Overall and bleeding-related discontinuation rates of a new oral contraceptive containing 4 mg drospirenone only in a 24/4 regimen and comparison to 0.075 mg desogestrel. Gynecol Endocrinol 2021 Aug 17:1-7. doi: 10.1080/09513590.2021.1963432.
PMID: 34402728